Cytotoxicity, Proapoptotic Activity and Drug-like Potential of Quercetin and Kaempferol in Glioblastoma Cells: Preclinical Insights
International Journal of Molecular Sciences · 05.10.2024 · 25 (19) · 10740
DOI: 10.3390/ijms251910740 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.10.2024. Verfasst von Magdalena Kusaczuk und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biochemistry, Medical University of Bialystok, Mickiewicza 2A, 15-222 Bialystok, Poland. Hauptthemen laut MEDLINE: Kaempferols, Quercetin, Glioblastoma, Apoptosis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Polish National Agency for Academic Exchange (NAWA), Instituto de Salud Carlos III (ISCIII), European Regional Development Fund (ERDF).
Abstract (Originalsprache)
Despite the increasing understanding of the pathogenesis of glioblastoma (GBM), treatment options for this tumor remain limited. Recently, the therapeutic potential of natural compounds has attracted great interest. Thus, dietary flavonoids quercetin (QCT) and kaempferol (KMF) were investigated as potential cytostatic agents in GBM. Moreover, the physicochemical properties of QCT and KMF, determining their bioavailability and therapeutic efficiency, were evaluated. We proved that both polyphenols significantly reduced the viability of GBM cells. We also demonstrated that both QCT and KMF evoked the cytotoxic effect in T98G cells via induction of apoptotic cell death as shown by increased activity of caspase 3/7 and caspase 9 together with an overexpression of the cleaved form of PARP. Apoptosis was additionally accompanied by the activation of stress responses in QCT- and KMF-treated cells. Both polyphenols caused oxidative stress and endoplasmic reticulum (ER) stress, as demonstrated by the increased generation of reactive oxygen species (ROS), deregulated expressions of superoxide dismutases (SOD2 and Sod1 on protein and transcriptomic levels, respectively), as well as an overexpression of ERO1α, GRP78, p-JNK, and an up-regulation of Chop, Atf4 and Atf6α genes. The antitumor effect of QCT and KMF was also confirmed in vivo, showing reduced growth of tumor xenografts in the chick chorioallantoic membrane (CAM) experiment. Moreover, electrophoretic light scattering (ELS) was used to measure the zeta potential of cell membranes upon exposition to QCT and KMF. Additionally, on the basis of existing physicochemical data, the drug-likeness score of QCT and KMF was evaluated. Analyses showed that both compounds accomplish Lipinski’s Rule of 5, and they both fit into the criteria of good central nervous system (CNS) drugs. Altogether, our data support the idea that QCT and KMF might be plausible candidates for evaluation as therapeutic agents in preclinical models of glioblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Biochemistry, Medical University of Bialystok, Mickiewicza 2A, 15-222 Bialystok, Poland.
- Department of Biochemistry and Molecular Biology, School of Biology, Complutense University and Instituto de Investigación Sanitaria San Carlos IdISSC, 28040 Madrid, Spain.
- Department of Physiology, Medical University of Bialystok, Mickiewicza 2C, 15-222 Bialystok, Poland.
- Department of Physical Chemistry, Faculty of Chemistry, University of Bialystok, K. Ciolkowskiego 1K, 15-245 Bialystok, Poland.
ORCID-Profile: Elena Tovar-Ambel, Paola Martín-Cabrera, Mar Lorente, Nélida Salvador-Tormo, Agnieszka Mikłosz, Adrian Chabowski, Guillermo Velasco, Monika Naumowicz
Förderung
- Polish National Agency for Academic Exchange (NAWA)
- Instituto de Salud Carlos III (ISCIII)
- European Regional Development Fund (ERDF)
- Madrid Region Government Network Program in Biosciences
- Madrid regional government
Zitieren
APA
Kusaczuk, M., Tovar-Ambel, E., Martín-Cabrera, P., Lorente, M., Salvador-Tormo, N., Mikłosz, A., Chabowski, A., Velasco, G., & Naumowicz, M. (2024). Cytotoxicity, Proapoptotic Activity and Drug-like Potential of Quercetin and Kaempferol in Glioblastoma Cells: Preclinical Insights. International Journal of Molecular Sciences, 25(19), 10740. https://doi.org/10.3390/ijms251910740
Vancouver
Kusaczuk M, Tovar-Ambel E, Martín-Cabrera P, Lorente M, Salvador-Tormo N, Mikłosz A, et al. Cytotoxicity, Proapoptotic Activity and Drug-like Potential of Quercetin and Kaempferol in Glioblastoma Cells: Preclinical Insights. International Journal of Molecular Sciences. 2024;25(19):10740. doi:10.3390/ijms251910740
BibTeX
@article{Kusaczuk2024,
author = {Kusaczuk, Magdalena and Tovar-Ambel, Elena and Martín-Cabrera, Paola and Lorente, Mar and Salvador-Tormo, Nélida and Mikłosz, Agnieszka and Chabowski, Adrian and Velasco, Guillermo and Naumowicz, Monika},
title = {Cytotoxicity, Proapoptotic Activity and Drug-like Potential of Quercetin and Kaempferol in Glioblastoma Cells: Preclinical Insights},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {19},
pages = {10740},
doi = {10.3390/ijms251910740}
}
EUVIMED